Literature DB >> 23192650

Cerebral capillary telangiectasias: a meta-analysis and review of the literature.

Bradley A Gross1, Ajit S Puri, A John Popp, Rose Du.   

Abstract

As a result of their presumed benign natural history, cerebral capillary telangiectasias (CCTs) are infrequently addressed in the neurosurgical literature. We performed a comprehensive review of CCTs via the PubMed database to synthesize overall epidemiological, radiographic, natural history, and treatment results. Across ten series with 203 patients, mean age was 47, and 45 % were male [95 % confidence interval (CI), 0.30-0.65]. Notably, 78 % of CCTs were in the pons (95 % CI, 0.58-1.0). Six percent of CCTs were symptomatic. Across five radiographic series, all lesions enhanced after gadolinium, and all were hypointense on gradient echo sequences. Thirty-three percent were hypointense on T1-weighted pre-contrast imaging (95 % CI, 0.2-0.51), 49 % were hyperintense on T2-weighted imaging (95 % CI, 0.31-0.72), and 74 % were hypointense on diffusion-weighted imaging (95 % CI, 0.5-1.0). Notably, 37 % were associated with a prominent draining vein (95 % CI, 0.21-0.6), and 11 % with a developmental venous anomaly (95 % CI, 0.04-0.25). Across four observational studies with 47 patients, there was no observed change in lesion morphology or hemorrhage in 65.7 patient-years of follow-up. Although the vast majority of CCTs are managed conservatively, we found ten cases of patients treated with surgical excision. We confirm that CCTs are a benevolent entity with a predilection for the pons. They have distinctive radiographic features including their lack of mass effect, consistent enhancement on T1-weighted sequences and hypointensity on gradient echo sequences, and common isointensity on pre-contrast T1-weighted and T2-weighted images. Management for these lesions has been nonoperative in almost all cases.

Entities:  

Mesh:

Year:  2012        PMID: 23192650     DOI: 10.1007/s10143-012-0435-9

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  42 in total

Review 1.  The natural history of intracranial cavernous malformations.

Authors:  Bradley A Gross; Ning Lin; Rose Du; Arthur L Day
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

2.  MRI using ferumoxytol improves the visualization of central nervous system vascular malformations.

Authors:  Edit Dósa; Suchita Tuladhar; Leslie L Muldoon; Bronwyn E Hamilton; William D Rooney; Edward A Neuwelt
Journal:  Stroke       Date:  2011-04-14       Impact factor: 7.914

3.  The juxtaposition of a capillary telangiectasia, cavernous malformation, and developmental venous anomaly in the brainstem of a single patient: case report.

Authors:  R E Clatterbuck; I Elmací; D Rigamonti
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

4.  Telangiectases and cavernous angiomas of the brainstem: "cryptic" vascular malformations. Report of a case.

Authors:  G H Roberson; C S Kase; E R Wolpow
Journal:  Neuroradiology       Date:  1974-10       Impact factor: 2.804

5.  The pathology of vascular ("arteriovenous") malformations.

Authors:  W F McCormick
Journal:  J Neurosurg       Date:  1966-04       Impact factor: 5.115

6.  Developmental venous anomaly, cavernous malformation, and capillary telangiectasia: spectrum of a single disease.

Authors:  A Abla; S D Wait; T Uschold; G P Lekovic; R F Spetzler
Journal:  Acta Neurochir (Wien)       Date:  2008-03-26       Impact factor: 2.216

7.  Mixed vascular malformations of the brain: clinical and pathogenetic considerations.

Authors:  I A Awad; J R Robinson; S Mohanty; M L Estes
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

Review 8.  Clinical, radiological, and pathological spectrum of angiographically occult intracranial vascular malformations. Analysis of 21 cases and review of the literature.

Authors:  R D Lobato; C Perez; J J Rivas; F Cordobes
Journal:  J Neurosurg       Date:  1988-04       Impact factor: 5.115

9.  Stereotactic microresection of small cerebral vascular malformations (SCVM).

Authors:  K D Lerch; D Schaefer; H Palleske
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Angiographically occult arteriovenous malformations.

Authors:  C S Ogilvy; R C Heros; R G Ojemann; P F New
Journal:  J Neurosurg       Date:  1988-09       Impact factor: 5.115

View more
  7 in total

1.  [Intracranial vascular malformations].

Authors:  D F Vollherbst; M Bendszus; M A Möhlenbruch
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

2.  Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson's disease: a longitudinal analysis.

Authors:  Jared J Tanner; Shellie-Anne Levy; Nadine A Schwab; Loren P Hizel; Peter T Nguyen; Michael S Okun; Catherine C Price
Journal:  Clin Neuropsychol       Date:  2016-11-04       Impact factor: 3.535

3.  Diagnosis and treatment of vascular malformations of the brain.

Authors:  Bradley A Gross; Rose Du
Journal:  Curr Treat Options Neurol       Date:  2014-01       Impact factor: 3.598

4.  Symptomatic and Stenotic Developmental Venous Anomaly with Pontine Capillary Telangiectasia: A Case Report with Genetic Considerations.

Authors:  Daiichiro Ishigami; Satoshi Koizumi; Satoru Miyawaki; Hiroki Hongo; Yu Teranishi; Jun Mitsui; Nobuhito Saito
Journal:  NMC Case Rep J       Date:  2022-05-31

Review 5.  Cerebral vascular malformations and their imaging modalities.

Authors:  Atif Zafar; Brian Fiani; Hamid Hadi; Mohammad Arshad; Alessandra Cathel; Muhammad Naeem; Matthew S Parsons; Mudassir Farooqui; Abigail A Bucklin; Michael J Leone; Aqsa Baig; Syed A Quadri
Journal:  Neurol Sci       Date:  2020-04-25       Impact factor: 3.307

Review 6.  Systemic and CNS manifestations of inherited cerebrovascular malformations.

Authors:  Blaine L Hart; Marc C Mabray; Leslie Morrison; Kevin J Whitehead; Helen Kim
Journal:  Clin Imaging       Date:  2021-01-20       Impact factor: 2.420

7.  Neuroradiological Manifestations of Hereditary Hemorrhagic Telangiectasia in 139 Japanese Patients.

Authors:  Masaki Komiyama; Aiko Terada; Tomoya Ishiguro; Yusuke Watanabe; Hideki Nakajima; Osamu Yamada; Hiroko Morisaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-06-02       Impact factor: 1.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.